Betaxolol - currently sold under brand names Betoptic, Betoptic S, Lokren, Kerlone and others - is a prescription drug used to treat glaucoma and ocular hypertension. It was patented in 1975 and was first licenced for medical use over forty years ago.
Its mechanism of action is unknown.
There are no published data detailing the pharmacokinetic properties of betaxolol following ocular administration in humans; such information is important to assess the extent of systemic availability.
Source : Drugs, volume 40, pages 75–90
Also see :
Ideas for new topics, and suggested additions / corrections for old ones, are always welcome.
If you have skills or interests in a particular field, and have suggestions for Wikenigma, get in touch !
Or, if you'd like to become a regular contributor . . . request a login password. Registered users can edit the entire content of the site, and also create new pages.
( The 'Notes for contributors' section in the main menu has further information and guidelines etc.)
You are currently viewing an auto-translated version of Wikenigma
Please be aware that no automatic translation engines are 100% accurate, and so the auto-translated content will very probably feature errors and omissions.
Nevertheless, Wikenigma hopes that the translated content will help to attract a wider global audience.